Elion Therapeutics closes $81 million in Series B funding round led by Deerfield Management and AMR Action Fund to advance SF001, a next-generation polyene antifungal designed for reduced toxicity.
Amount Raised
$81 Million
Round Type
Series B
New YorkBiotechnologyHealth CareInvestors
Description
Elion Therapeutics, a biotechnology company, has closed a $81 million Series B funding round to support the advancement of SF001, a next-generation polyene antifungal designed for reduced toxicity. The round was led by Deerfield Management and the AMR Action Fund, with additional investment from Illinois Ventures.
Quick answer
Elion Therapeutics raised $81 Million in a Series B round, dated June 17, 2024. Investors: Illinois Ventures, AMR Action Fund and Deerfield Management. Elion Therapeutics is based in New York, New York, United States.
- How much did Elion Therapeutics raise?
- Elion Therapeutics raised $81 Million in a Series B round on June 17, 2024.
- Who invested in Elion Therapeutics?
- Illinois Ventures, AMR Action Fund and Deerfield Management are named as investors in this round.
- What does Elion Therapeutics do?
- Elion Therapeutics, formerly Sfunga Therapeutics, is a biotechnology company dedicated to transforming the treatment of life-threatening invasive fungal infections (IFIs).
- Where is Elion Therapeutics based and how big is it?
- Elion Therapeutics is based in New York, New York, United States.
- Who are the decision-makers at Elion Therapeutics?
- Fundz holds 1 contact at Elion Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Elion Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Healx raised $47M (Series C) on August 1, 2024.
- Vital Care raised an undisclosed amount (Corporate Round) on August 1, 2024.
- Lipella Pharmaceuticals raised $120K on July 31, 2024.
- Convergent Therapeutics raised $22M on July 31, 2024.
- Airna raised $60M (Series A) on July 31, 2024.
- Protembis GmbH raised $22M (Debt Financing) on July 30, 2024.
Who to call at Elion Therapeutics, and when
A new round usually means Elion Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Elion Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Elion Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Elion Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Elion Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansElion Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.